Nuovo
FebriDx® Rapid Respiratory Test
0 Recensioni
Pubblicato Di RCS Healthcare
$612.50 (USD)
- Posizione: United States
- Stato: Disponibile
Detagli
FebriDx® Rapid Respiratory Test is a rapid point-of-care **** that differentiates bacterial infections from non-bacterial pathogens. In 10 minutes, this portable **** allows medical providers to initiate the correct treatment and a**** the overuse of antibiotics.
Features and Benefits:
Allows medical providers to identify or rule out bacterial infections
Delivers results within 10 minutes
No equipment necessary
Reduces the need to write antibiotic prescriptions
99% Negative predictive value
CLIA Moderate Waived Test
prodotti correlati
